Axel Radlach Pries

Vivantes-Netzwerk für Gesundheit GmbH is a hospital operating company based in Berlin, Germany. The German company operates hospitals and is ultimately controlled by the City of Berlin. The CEO of the company is Andrea Grebe.

Part of Ernst & Young Global Ltd., Ernst & Young GmbH Wirtschaftsprüfungsgesellschaft is a German company that provides accounting and tax preparation services. The company is based in Stuttgart, Germany. The CEOs are Andreas Volker Muth, Jan Brorhilker, Jan-Rainer Hinz. The company was founded in 2009.

Wirtschaftsrat der CDU eV operates as a business association. The non-profit company is based in Berlin, Germany.

Part of Verein für Berliner Stadtmission eV, Berliner Stadtmission Gemeinnützige Diakonie Betriebs GmbH is a company based in Berlin, Germany that operates over 90 facilities to help people in various emergency situations. The German company provides assistance and support to people in need, and creates a positive impact in the community. The company's description emphasizes the importance of helping those in need, and highlights their efforts to provide children with educational programs that teach them about poverty and homelessness.

Schöler Fördertechnik AG is a private company based in Rheinfelden, Germany. Schöler Fördertechnik AG wholesales industrial trucks and vehicles. The German company was founded in 1966 and is led by CEO Ulrich Kurz.

Vivantes Ida-Wolff-Krankenhaus GmbH is a private company based in Berlin, Germany. The CEOs of the German company are Andrea Grebe, Johannes Danckert.

Vivantes - MVZ GmbH is a medical center based in Berlin, Germany, with CEOs Andrea Grebe and Axel Roesler. The German company provides outpatient care for gastroenterological, hepatological, and psychological diseases, as well as primary care. The medical centers of Vivantes offer both general and specialized medical care. The company is ultimately controlled by the City of Berlin.

Werfen SA operates as a vitro diagnostics company to provide solutions for hospitals and commercial laboratories for the improvement of patient care. It is in the specialties of hemostasis, acute care diagnostics and autoimmunity. The company was founded in 1966 by Jose Maria Rubiralta Vilaseca and is headquartered in Barcelona, Spain.

Werfen NV is a Belgian company that unites its subsidiaries, including Instrumentation Laboratory (IL), Inova Diagnostics (Inova), and Biokit, under one brand name, Werfen. The private company is based in Zaventem, Belgium. The company has completed organizational transitions and adopted a new brand identity, including a new corporate logo. Werfen has been known as Werfen outside of Belgium since 2014. Werfen was founded in 1966, and the CEO is Carlos Pascual.

Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999.

Part of Roche Holding AG, Roche Diagnostics Belgium NV is a Belgian company that develops innovative products and services for the prevention, diagnosis, monitoring, screening, and treatment of diseases. Roche Diagnostics Belgium is based in Diegem, Belgium, and was founded in 1958. The company offers next-generation sequencing products and in vitro diagnostics that are an integral part of decision-making along the entire continuum of a patient's health or disease. The CEO is Thomas Schinecker.

Part of Roche Holding AG, Roche Diagnostics Scandinavia AB is a company that provides health care services. The company is based in Solna, Sweden. Matthew Sause has been the CEO of the Swedish company since 2023.

Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ.

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Part of Novartis AG, Roche Diagnostics AG is a Swiss healthcare company committed to improving lives through innovative medicines and diagnostic tests. The company is based in Rotkreuz, Switzerland. Roche has been a pioneer in healthcare since its founding in 1896 and has helped millions of patients worldwide.

Sellutions AG markets Apple products. The private company is based in Berlin, Germany. The German company was founded in 1991. The CEO is Archibald Horlitz.

Fiagon AG Medical Technologies operates as a holding company, which engages in the provision of electromagnetic surgical navigation solutions. It specializes in electromagnetic navigation for sinus, ear, cranio-maxillofacial, spine, and brain surgery. The company was founded by Timo Krüger and Dirk Mucha in 2007 and is headquartered in Hennigsdorf, Germany.

Mock-Rechtsanwälte GbR is a Berlin-based law firm founded in 2001. The firm provides legal advice to a diverse range of clients, including listed companies, medium-sized businesses, and start-ups. The German company's services cover property law and company law, and they offer personal advice by their partners. The firm advises German and international individuals and companies, corporate bodies under public law, and institutional investors. The firm's focus extends beyond Berlin, and they have clients from various locations.

Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany.

Industrie- und Handelskammer zu Berlin operates as a chamber of commerce. The company is based in Berlin, Germany and has subsidiaries in Germany.

TVM Capital GmbH (TVMC) is an international venture capital firm headquartered in Munich, Germany. Founded in 1983, the firm was formerly known as Techno Venture Management.

Anchor Therapeutics, Inc. designs and develops peptide modulators of G protein-coupled receptors (GPCRs). The firm engages in developing and licensing pepducin technology as a research tool for drug development; and pepducin drug candidates and novel molecules that are intended for targeting GPCR to allosterically modulate GPCR signaling. Its pepducin lipopeptides are designed to allosterically modulate internal cell signaling via specific interactions with intracellular GPCR domains. The company also focuses on developing its pepducin technology for creating new treatment options for regenerative medicine, diabetes, inflammation, and cancer. Anchor Therapeutics was founded by Thomas J. McMurry and Athan Kuliopulos in 2006 and is headquartered in Cambridge, MA.

Thermosome GmbH develops novel drugs for solid tumors. Its technology is used for delivery of various active pharmaceutical ingredients with its application in localized diseases. The company was founded by Lars Lindner, Martin Hossan and Hansjoerg Eibl and is headquartered in Planegg, Germany.

Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland.

Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA.

3B Pharmaceuticals GmbH is a German biotechnology company that specializes in developing targeted radiopharmaceutical drugs and diagnostics for oncology indications with a high unmet medical need. The company is based in Germany. The private company is a leader in peptide discovery and optimization, with a technology platform that extends from hit identification to early clinical development. The company is owned by its founders and management. 3BP was founded in 2008 by a team of renowned experts in peptide drug discovery and nuclear medicine from Bern and Basel. The company was founded in 2008 by Jochen Knolle. The CEO is Ulrich Reineke.

The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024.